NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 162 filers reported holding NEVRO CORP in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $654,000 | -5.9% | 11,473 | +31.8% | 0.08% | -11.5% |
| Q2 2018 | $695,000 | -48.2% | 8,703 | -32.3% | 0.09% | -59.7% |
| Q3 2016 | $1,342,000 | +41.4% | 12,860 | 0.0% | 0.22% | +36.7% |
| Q2 2016 | $949,000 | +85.0% | 12,860 | +40.9% | 0.16% | +79.5% |
| Q1 2016 | $513,000 | -16.7% | 9,125 | 0.0% | 0.09% | -8.3% |
| Q4 2015 | $616,000 | +45.6% | 9,125 | 0.0% | 0.10% | +39.1% |
| Q3 2015 | $423,000 | – | 9,125 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
| Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
| Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
| Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
| BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
| ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
| ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
| Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
| Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
| Olympiad Research LP | 25,046 | $210,887 | 0.16% |